Видео ютуба по тегу Jeffrey Ravetch

The Rockefeller Scientist - Jeffrey V. Ravetch, M.D., Ph.D.
The Rockefeller Scientist - Jeffrey V. Ravetch, M.D., Ph.D.
Jeffrey V. Ravetch- 2012 Canada Gairdner International Award
Jeffrey V. Ravetch- 2012 Canada Gairdner International Award
Lab Profile: Jeffrey V. Ravetch
Lab Profile: Jeffrey V. Ravetch
Scientist Stories: Jeffrey Ravetch, The Paradox of Immunity
Scientist Stories: Jeffrey Ravetch, The Paradox of Immunity
Dr. Jeffrey Ravetch: Fc Receptor Engineering to Enhance Antibody Therapeutics for SARS-CoV2
Dr. Jeffrey Ravetch: Fc Receptor Engineering to Enhance Antibody Therapeutics for SARS-CoV2
Истории ученых: Джеффри Раветч, разработка Fc-рецепторов для повышения эффективности антител в те...
Истории ученых: Джеффри Раветч, разработка Fc-рецепторов для повышения эффективности антител в те...
The Structural Basis for the Functional Diversity of the lmmunoglobulin Fc Domain | Jeffrey Ravetch
The Structural Basis for the Functional Diversity of the lmmunoglobulin Fc Domain | Jeffrey Ravetch
Professeur Jeffrey V. Ravetch, lauréat du Prix Sanofi-Institut Pasteur 2012
Professeur Jeffrey V. Ravetch, lauréat du Prix Sanofi-Institut Pasteur 2012
Minds that Matter: Gairdner Symposium 2020
Minds that Matter: Gairdner Symposium 2020
The Paradox of Immunity
The Paradox of Immunity
HEVs : specialized blood vessels for lymphocyte entry in tumors during cancer immunotherapy #TIJC
HEVs : specialized blood vessels for lymphocyte entry in tumors during cancer immunotherapy #TIJC
Breakthrough: Rockefeller's Engineered Antibody Replaces IVIG for Autoimmune Diseases
Breakthrough: Rockefeller's Engineered Antibody Replaces IVIG for Autoimmune Diseases
Next-Gen Antibody Replaces IVIG: Breakthrough for Autoimmune Diseases
Next-Gen Antibody Replaces IVIG: Breakthrough for Autoimmune Diseases
Революционно разработанные антитела: замена терапии внутривенными иммуноглобулинами при аутоиммун...
Революционно разработанные антитела: замена терапии внутривенными иммуноглобулинами при аутоиммун...
Antibody-Based Therapies: Taking a BiTE Out of Cancer
Antibody-Based Therapies: Taking a BiTE Out of Cancer
The Rockefeller Scientist - Jeffrey M. Friedman, M.D., Ph.D.
The Rockefeller Scientist - Jeffrey M. Friedman, M.D., Ph.D.
UCLA management professor Ravetch sing songs he wrote
UCLA management professor Ravetch sing songs he wrote
Jeffrey West at ARDD2025: Ecological, evolutionary, and interventional antifragility in medicine
Jeffrey West at ARDD2025: Ecological, evolutionary, and interventional antifragility in medicine
Michael Young- 2012 Canada Gairdner International Award
Michael Young- 2012 Canada Gairdner International Award
The Rockefeller Scientist - Mary E. Hatten, Ph.D.
The Rockefeller Scientist - Mary E. Hatten, Ph.D.
Introduction to Professor Roy Jefferis before his lectures on Antibodies to Masters students
Introduction to Professor Roy Jefferis before his lectures on Antibodies to Masters students